chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tingling in face and feet; elevated blood pressure; elevated heart rate; Dizziness; Brain fog; This is spontaneous report from a contactable consumer, the patient. A 41-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 10:45 (at the age of 41-years-old) as a single dose for Covid-19 immunisation. The patient medical history included asthma, reflux and migraine from unknown date. Allergies to medications, food, or other products was reported to cats. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included meloxicam, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), and ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN), all for unknown indication from unknown date. The patient experienced tingling in face and feet, elevated blood pressure, elevated heart rate, dizziness and brain fog on 17Mar2021 at 10:45. The patient did not receive treatment for the reported events. The clinical outcome of the tingling sensation, elevated blood pressure, heart rate increased, dizziness and foggy feeling in head was recovering.   No follow-up attempts are possible, information about batch number cannot be obtained.
Patient came in for her Bivalent booster. She said her last vaccination was July 2022. When I looked at her vaccine card, she again said her last dose was in July 2022, so she could get another one today. After I vaccinated her and went back to her profile to document the new dose, I realized that her last dose was in August 2022.
Headache, NauseaVomiting & HYPERtension Narrative:  after vaccine same day had nausea, headache, elevated BP, after 45 minutes felt better, went home to rest, had loose stools, better two days later
Very high fever with rigors, severe left sided uncontrollable headaches, dizziness, nausea, severe vomiting  unable to keep food down x 5 days, double vision-still persistent till date, insomnia, hearing loss worse on the left ear, ringing in the ear both ears, worse on the left still persist, and unresolved till date, numbness of left side of the body, and face.
This spontaneous report as received from a healthcare worker refers to an approximately 1 year old patient of unknown gender. On 04-NOV-2013 at 15:45 the patient was administered with M-M-R II (lot number J002867, expiry date 08-MAR-2015) (dosing regimen and frequency unknown) that was exposed to a cumulative time of 9.5 hours at temperatures of 8.0 degrees centigrade to 13.9 degrees centigrade. The patient experienced no adverse event. On the following date the M-M-R II was exposed to approximately for 9.5 hours at temperatures of 8.0 degrees centigrade to 13.9 degrees centigrade, on 07-OCT-2013 from 17:14 to 18:08 the vaccine experienced a temperature of 9.4 degrees centigrade, on 10-OCT-2013 from 09.50 to 13:26 the vaccine experienced a temperature of 13.9 degrees centigrade, on 14-OCT-2013 from 13:56 to 16:08 the vaccine experienced a temperature of 12.8 degrees centigrade, on 17-OCT-2013 from 08:38 to 09:44 the vaccine experienced a temperature of 9.7degrees centigrade, on 18-OCT-2013 from 11:50 to 13:08 the vaccine experienced a temperature of 9.7 degrees centigrade. This is one of the 17 reports received from same reporter. Additional information has been requested.
A bad rash developed on chest area and sporadic outbreaks on arms, legs and back.
Patient woke up on the morning of 1/21/21 with left facial numbness and loss of muscle tone of left face. She presented to her doctor who diagnosed Bell's Palsy. She has been treated with prednisone and acyclovir. she is awaiting a head CT-scan. Symptoms have stabilized  and perhaps slightly improved.
Bleeding under the skin since the covid vaccine; This is a spontaneous report from a contactable consumer. This consumer (patient's daughter) reported for a female patient (reporter's mother) via telephonic follow-up activity. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: unknown, Expiry date: not reported) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for Covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced bleeding under the skin since the covid vaccine. The event outcome was unknown.  Information about lot/batch number cannot be obtained. Additional information has been requested.
Large area over front of thigh of redness, induration tenderness. Treatment with cold compresses, Benadryl, Tylenol for home therapy.
so did I but still got shingles/Suspected Vaccination Failure; still got shingles; nerve pain; feel drained; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: so did I but still got shingles/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: still got shingles), nerve pain (Verbatim: nerve pain) and fatigue (Verbatim: feel drained). The outcome of the vaccination failure was unknown and the outcome of the shingles and fatigue were not reported and the outcome of the nerve pain was not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, nerve pain and fatigue to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, nerve pain and fatigue to be related to Shingles vaccine.   Additional Information: GSK receipt date: 20-MAR-2023 The case was received from the patient via interactive digital media. The patient stated so did he/she but still got shingles and now had the nerve pain (at the time of reporting). The patient was awful and felt drained and just started acupuncture. The patient hoped that help. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Developed pneumonia 5 days was hospitalized 2 days later and tested positive for covid pneumonia
Initially developed extreme fatigue, malaise and sense of taste/smell became ranacid continuing to current date. States he just felt sick. On May 7th developed seizure x2, brain swelling and multiple lesions on brain MRI. Work up noted normal carotid, normal cerebral arteries and veins. Stroke work up negative. Follow up MRI June 9th appeared with additional lesions. Seen by neurology, neurosurgery and oncology. Most recent MRI August 19th showed marked improvement in lesions. Neurology visit 8/27/21 reported he has sustained encephalitis as an autoimmune response to COVID vaccine.
I began having severe diarrhea and the doctor diagnosed it with IBS and getting me a diet to follow. And the Doctor gave me the pills to manage the symptoms. I have been utilizing the diet and the med and it's been helping. I still have to follow the diet really strictly that. The meds the doctor has me on now are:  Ibgard - for IBS  - 2 capsules once a day;  Imodium - often times it's about every other day.  I think I had been having intermittent symptoms like this for a longer period of time before the vaccines but hadn't had to address it with meds and diet until  these severe symptoms at the end of August. I had seen the doctor on July 14th and she had given me an IBS diagnosis, though. This is a a chronic situation and as long as I adhere to a pretty strict diet it won't be as severe.
This spontaneous report was received from a doctor of pharmacy refers to a patient of unknown age who on 14-SEP-2012, was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot number 671004/0729AA) that was expired. The vaccine expired on 17-AUG-2012. No adverse effects were reported. Additional information has been requested.
fever from 6:30pm 1/28/2021 to 1:30pm 1/30/2021; Achy, tired
She arrived at 12:30 and was vaccinated shortly after while waiting 15 for observation within the 1st 10 min she C/O tingling of her throat and lower lips, felt palpitation. No chills, No headache, + palpitations, and No presyncope. Tells me that she did not experience any loss of consciousness. Never had any chest pain, shortness of breath, or angioedema, rash, pruritus, throat swelling, hoarse voice, or difficulty breathing. The patient has had no recent illnesses, fevers, chills, nausea, vomiting, diarrhea, or flu-like illnesses. She has had no cough, rhinorrhea, or congestion. She denies any recent vaginal bleeding, or abdominal pain. Denies any history of cardiac disease, or history of arrhythmias. Denies any history of prolonged immobility, recent travels, or history of clots. In ED:32 year old  female with PMHx as listed in HPI presents with concern for allergic reaction to mod chair and a COVID-19 vaccine, felt tingling in the back of her throat and lower lip, no swelling, wheezing, shortness of breath, throat tightening, rash, nausea vomit or dizziness.  Vitals reviewed found to be within normal limit.  Physical exam as per above, no signs of mucosal or oral swelling, no hives or rash and no wheezing on exam.  Given above findings, low suspicion for allergic reaction this time but plan to observe patient in the ED for any delayed reaction.
Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient had received 2 shots from us.  She got up & went to drop off window & said she was a little lightheaded then passed out walking to the chairs.  She said she had not eaten anything that day.  Her mother came & picked her up.
Belle's Palsy a few days after Gardasil #2 resolved in 24 hrs, had a migraine . Labs are being ordered
This spontaneous report as received from an unspecified reporter refers to an unspecified number of patients of unknown age and gender. Medical histories and concurrent conditions were not reported. The reporter stated that he personally knew people who have had side effects after they were vaccinated with M-M-R II (dose, route, lot number and expiation date were not provided). The caller also reported that an unspecified physician told him that some patients had developed measles after receiving M-M-R II (dose, route, lot number and expiration date were not provided). The reporter did not gave any concrete information about patients, side effects or dates of vaccinations or onset dates of events. Additional information is not expected, as there is no contact information to follow up.
Received vaccine at 5pm on 1-2-08. Next morning when my daughter awoke at 5:30am, her face was red and swollen. Even around her eyes were swollen. It looked like a sunburn. No other symptoms, gave Benadryl, still seems to have it. Called her doctor, was told to just keep giving Benadryl.
29yo female patient with no PMH. Approximately 15min after receiving the Pfizer Booster vaccine she felt "lightheaded". She states that she is fasting and hasn't eat anything today. Patient was evaluated by on-site EMS and MD. Noted to be AAO x 3; Initial VS: HR 88, RR 18, SpO2 100%, BP 118/86. On physical exam clear breath sounds bilaterally, RRR, Cap refill <2sec. Denied any nausea, vomiting, vision changes or paresthesia. Patient was offered apple juice (12oz) which she drank. After 15min observation patient felt better. Repeated set of VS within normal limits. Patient was discharged home with complete resolution of symptoms.
Pt appears to be in second or third stage of Lyme disease, numbness and pain in arm or legs, pt has both. She is having severe headaches and neck creaks and cracks with stiffness. Fatigue has worsened to point she can't say awake during public meetings, feels drained. Chills and sweats off and on for a year or more. Muscle and joint pains, shooting pains, burning, tingling and numbness and burning in feet. Feeling light headed and woozy by midday to remaining of day. Left eye twitching and bumping into things from feeling disoriented or perception is off. Reported to friend that I was seeing light spots shooting across room (floater), and restlessness, reoccurring ear pain and sensitive to any thing loud. I have been dx with fibromayalgia.
I experienced itchiness and redness at the injection site for 5 days.  The area was also warm to the touch.
PAIN AND RANGE OF MOTION LIMITED. UNABLE TO LIFT ARM COMFORTABLY ABOVE HEAD, LOSS OF STRENGTH, INABILITY TO GET COMFORTABLE LYING ON SIDE
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent condition, medical history or concomitant medications were not reported. The nurse reported that on 27-JUL-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K009953, expiry date 03-APR-2016 (dose and route of administration unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient returned to pharmacy this morning with a complaint of redness and heat a bit below the site of injection. She got the shot on 05/25 and noticed the redness on 05/26. The site was not swollen but it was hot to the touch. She denies fever, nausea, or feeling ill. She was told to use ice pack and monitor, if the site spreads, starts to swell, becomes painful or if she becomes febrile to go to ER or urgent care immediately as it could mean infection.
Pt had jerking reaction  including right arm/forearm and abdomen, cold feeling in arm and anxiety
I developed a fever, body aches, headache, and nausea the next morning after the shot.    These have lasted all day today.
Localized pain at injection site, raspiness of voice, itchy eyes, itching on back, arms and legs, bruising at injection site, malaise, sinus congestion, cough, repeating headache, fever, ache all over even with NSAIDs, some persistent symptoms present six days post injection.
On September 1st I found a lump on my nodule. I went to see the doctor at Valley Medical group, and I haven't got a diagnosis yet. I will have another biopsy done in December 2021. I am on the same medications, and I have had the Merina device removed.
viral exanthema, anthralgia - information has been received from a physician concerning a female with no known drug allergies who at 15 month of age, in 1998, was vaccined with her first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation.  The physician reported that two weeks after the vaccination the patien developed a red viral rash with joint pain.  The patient did not seek medial attention. In follow up the physician reported the patien was seeing another physician at the time of her 15 month mmr.  he reported, she now comes to me and is currently 5 years old.  i called because of the history or reaction three years ago at another physician's office.
In Jun2022, the patient experienced COVID; In Jun2022, the patient experienced COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4449823-00.  A 63-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown), all intramuscular for covid-19 immunisation; adalimumab (HUMIRA), as 40 mg (citrate free (1 in 2 wk) (Batch/Lot number: unknown) subcutaneous for colitis ulcerative. The patient's relevant medical history included: "Interchange of vaccine products" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "not recovered" and all described as "In Jun2022, the patient experienced COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. The action taken for adalimumab was unknown. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
No adverse event; 14 doses of the Moderna COVID-19 vaccines were administered after the 30 day BUD between 15-MAY-2023 to 10-JUN-2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (14 doses of the Moderna COVID-19 vaccines were administered after the 30 day BUD between 15-MAY-2023 to 10-JUN-2023) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (14 doses of the Moderna COVID-19 vaccines were administered after the 30 day BUD between 15-MAY-2023 to 10-JUN-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (14 doses of the Moderna COVID-19 vaccines were administered after the 30 day BUD between 15-MAY-2023 to 10-JUN-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (14 doses of the Moderna COVID-19 vaccines were administered after the 30 day BUD between 15-MAY-2023 to 10-JUN-2023).    Concomitant medication was not provided. Suspect product dosage text was reported as unknown. It was reported that 14 doses of the Moderna COVID-19 vaccines were administered after the 30 day BUD between 15-MAY-2023 to 10-JUN-2023. Treatment information was not reported.  This case contains information about patient 13th out of 14 elderly patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-732456 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732456:Master case
Hospitalization: 2/4/2023 - 2/8/2023 (4 days) Presentation to the ED: BILATERAL PNEUMONIA & UTI. COVID + date: 2/4/23. Treatment: steroids  Discharge to: HOSPICE - EXPIRED 2/9/23. 038K20A 1/29/2021 023M20A 2/26/2021 047C21A 11/4/2021 027L21A 4/13/2022
Admitted to hospital on 11/01/21  H&P: primary dx hypertensive heart; ckd with heart failure; other dx dm2, ckd4, asthma, insomnia, O2 dependent, steroids, anticoag, asa, opite analgesic, hx tia, pacemaker, hx falls  pt found unresponsive in room  by nurse on the morning of 11/01/21.
Patient presented to ED on 02/06/2022 with SOB.  Patient required 100% nonrebreather, and continued to be tachypneic, and hypotensive.  Patient was placed on BiPAP and was barely able to maintain oxygen saturation 91-92% with  100% FiO2.  Patient was given fluid resuscitation and placed on dopamine drip.  She was given IV Rocephin and Iv cipro after blood cultures collected.  Patients daughter decided for the patient to be comfort care only.  Dopamine drip was discontinued, was placed on 100% nonrebreather and was given morphine 2mg IV every hour.  Patient was found to be Covid positive.  Patient expired in ED on 02/06/2022.
worse worse is she have like a shot that goes and came again in her leg.; everything on her body is hurting; join pain; muscle pain; headache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (worse worse is she have like a shot that goes and came again in her leg.), PAIN (everything on her body is hurting), PAIN IN EXTREMITY (join pain), MYALGIA (muscle pain) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension.   On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (worse worse is she have like a shot that goes and came again in her leg.), PAIN (everything on her body is hurting), PAIN IN EXTREMITY (join pain), MYALGIA (muscle pain), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (worse worse is she have like a shot that goes and came again in her leg.), PAIN (everything on her body is hurting), PAIN IN EXTREMITY (join pain), MYALGIA (muscle pain), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) had not resolved.            Tylenol Used as a Treatment Medication. No Concomitant Medication was provided by reporter.
Information has been received from a registered nurse concerning a 20 month old male who on 03-AUG-2007 was vaccinated SC with a 0.5 ml dose of PROQUAD (lot# 656164/1353F). Concomitant vaccinations administered on that same day included a dose hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (MSD), a dose poliovirus inactivated (unspecified), a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and a dose of hepatitis A vaccine (unspecified) (manufacturer unknown). On 17-FEB-2008 the patient experienced diagnosed with chickenpox characterized by a rash on the neck and trunk of less than 50 lesions. The patient sought medical attention through a physician office visit. No labs or diagnostic studies were performed. Subsequently, the patient recovered. There was no product quality complaint. No further information is available.
The evening of 1/24/08 patient noticed LUE to have a "sore raised hard area." Came to Dr's office on 1/25/08 at 3:45 pm 7x6 cm area of erythema and induration noted. Pt also c/o it was "itchy". Denies pain. Dr prescribed Allegra bid and hydrocortisone ointment 2.5% to affected area. Pt instructed to return to MD if Sx worsen or if not resolved by next week.
severe headache, fever, itching, rash (looks like shingles), cold sore